Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
An Iranian, an Israeli, and a Palestinian neuroscientist walked into a bar…
That chance occurrence at an SfN social led us to organize the Middle Eastern Systems Neuroscience Symposium, and forge a plan to build a community that transcends political barriers through scientific connection.
An Iranian, an Israeli, and a Palestinian neuroscientist walked into a bar…
That chance occurrence at an SfN social led us to organize the Middle Eastern Systems Neuroscience Symposium, and forge a plan to build a community that transcends political barriers through scientific connection.
Federal advisory panel extends comment period, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 27 July.
Federal advisory panel extends comment period, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 27 July.
Oregon primate research center to downsize monkey colony, pivot to non-animal models
The center’s host university had been negotiating with the federal government about converting the center into an animal sanctuary. A new plan, approved today, preserves some of the center’s nonhuman primate studies.
Oregon primate research center to downsize monkey colony, pivot to non-animal models
The center’s host university had been negotiating with the federal government about converting the center into an animal sanctuary. A new plan, approved today, preserves some of the center’s nonhuman primate studies.